Zdrowie i gospodarka · 08/03/2010
FDA Releases Guidance on Nonclinical Evaluation for Anticancer Pharmaceuticals
The FDA has made available a guidance document outlining internationally accepted recommendations for nonclinical studies to support the development of anticancer pharmaceuticals, developed under the ICH auspices.
Source: Federal Register — Health and Human ServicesOpen original release →